NZD 0.22
(14.36%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 | 29.17 Million NZD | 19.22% |
2023 | 19.47 Million NZD | -5.65% |
2022 | 23.36 Million NZD | 52.12% |
2021 | 23.28 Million NZD | -19.04% |
2020 | 18.16 Million NZD | 60.94% |
2019 | 9.67 Million NZD | 1.13% |
2018 | 8.66 Million NZD | 80.1% |
2017 | 6.08 Million NZD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 5.5 Million NZD | -20.92% |
2024 Q3 | 5.02 Million NZD | -66.06% |
2024 Q4 | 5.02 Million NZD | 186.57% |
2024 FY | - NZD | 15.07% |
2024 Q2 | 12.24 Million NZD | 168.9% |
2023 FY | - NZD | -5.65% |
2023 Q2 | 10.2 Million NZD | 185.88% |
2023 Q4 | 8.3 Million NZD | 168.86% |
2023 Q3 | 3.09 Million NZD | -69.71% |
2023 Q1 | 3.56 Million NZD | -63.61% |
2022 Q3 | 3.56 Million NZD | -66.59% |
2022 Q2 | 10.68 Million NZD | 201.72% |
2022 Q4 | 9.8 Million NZD | 174.81% |
2022 FY | - NZD | 52.12% |
2022 Q1 | 3.54 Million NZD | -45.81% |
2021 Q2 | 13.85 Million NZD | 238.9% |
2021 FY | - NZD | -19.04% |
2021 Q3 | 2.42 Million NZD | -82.5% |
2021 Q4 | 6.53 Million NZD | 169.61% |
2021 Q1 | 4.08 Million NZD | -64.92% |
2020 Q2 | 10.52 Million NZD | 269.23% |
2020 Q4 | 11.65 Million NZD | 292.26% |
2020 Q1 | 2.85 Million NZD | 0.0% |
2020 Q3 | 2.97 Million NZD | -71.77% |
2020 FY | - NZD | 60.94% |
2019 FY | - NZD | 1.13% |
2018 FY | - NZD | 80.1% |
2017 FY | - NZD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Arvida Group Limited | 181.88 Million NZD | 83.958% |
Oceania Healthcare Limited | 53.36 Million NZD | 45.322% |
Ryman Healthcare Limited | -91.21 Million NZD | 131.989% |
Summerset Group Holdings Limited | 22.51 Million NZD | -29.571% |
Third Age Health Services Limited | 2.99 Million NZD | -873.899% |